|
Market Closed -
Bombay S.E.
23:48:20 2026-08-23 EDT
|
5-day change | 1st Jan Change | ||
| 4,866.80 INR | -0.28% |
|
-0.07% | +27.33% |
| 07-30 | Torrent Pharmaceuticals Limited, Q1 2027 Earnings Call, Jul 30, 2026 | |
| 07-30 | Torrent Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| Market Cap | 1,856B 19.4B 16.62B 15.55B 14.23B 26.72B 27.07B 184B 71.65B 933B 72.85B 71.27B 3,084B | P/E 2027 * |
72.5x | P/E 2028 * | 52.5x |
|---|---|---|---|---|---|
| Enterprise Value | 1,978B 20.68B 17.71B 16.57B 15.17B 28.47B 28.85B 196B 76.36B 994B 77.64B 75.95B 3,287B | EV / Sales 2027 * |
9.99x | EV / Sales 2028 * | 8.75x |
| Free-Float |
36.58% | Yield 2027 * |
0.67% | Yield 2028 * | 0.78% |
Last Transcript: Torrent Pharmaceuticals Limited
| 1 day | +0.23% | ||
| 1 week | -0.07% | ||
| Current month | -4.14% | ||
| 1 month | -1.37% | ||
| 3 months | +6.99% | ||
| 6 months | +11.21% | ||
| Current year | +27.33% |
| 1 week | 4,860 |  | 5,045 |
| 1 month | 4,806 | | 5,249.95 |
| Current year | 3,724.1 | | 5,249.95 |
| 1 year | 3,480 | | 5,249.95 |
| 3 years | 1,771.35 | | 5,249.95 |
| 5 years | 1,242.5 | | 5,249.95 |
| 10 years | 571.75 | | 5,249.95 |
| Manager | Title | Age | Since |
|---|---|---|---|
Aman Samir Mehta
CEO | Chief Executive Officer | 34 | 2025-07-31 |
Sudhir Menon
DFI | Director of Finance/CFO | - | 2018-08-31 |
Geena Malhotra
CTO | Chief Tech/Sci/R&D Officer | - | 2026-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 62 | 2014-07-29 | |
Nayantara Bali
BRD | Director/Board Member | 59 | 2019-03-06 |
| Director/Board Member | 58 | 2022-07-28 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11/29/24 | Buy | Chief Operating Officer | 930,144 | 0.2748% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.28% | -0.07% | +33.26% | +149.51% | 19.4B | |
| +0.88% | +6.38% | +76.40% | +126.87% | 1,119B | |
| +1.07% | +3.80% | +50.73% | +64.25% | 651B | |
| +1.20% | +6.21% | +25.81% | +80.15% | 468B | |
| +1.02% | +5.77% | +43.63% | +43.06% | 374B | |
| +0.85% | +4.07% | +24.97% | +41.00% | 302B | |
| +1.26% | +6.81% | +2.27% | +13.65% | 259B | |
| +1.88% | +5.81% | +49.57% | +70.71% | 238B | |
| +1.59% | +2.09% | -17.33% | -53.85% | 208B | |
| +1.87% | +5.61% | +27.32% | +89.67% | 181B | |
| Average | +1.19% | +4.74% | +31.66% | +62.50% | 381.93B | |
| Weighted average by Cap. | +1.13% | +5.37% | +44.20% | +72.82% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 198B 2.07B 1.77B 1.66B 1.52B 2.85B 2.89B 19.6B 7.64B 99.49B 7.77B 7.6B 329B | 223B 2.33B 1.99B 1.87B 1.71B 3.21B 3.25B 22.05B 8.6B 112B 8.74B 8.55B 370B |
| Net income | 24.72B 258M 221M 207M 190M 356M 360M 2.45B 954M 12.42B 970M 949M 41.08B | 34.25B 358M 307M 287M 263M 493M 499M 3.39B 1.32B 17.21B 1.34B 1.32B 56.91B |
| Net Debt | 122B 1.28B 1.09B 1.02B 936M 1.76B 1.78B 12.07B 4.71B 61.29B 4.79B 4.68B 203B | 93.6B 978M 838M 784M 718M 1.35B 1.36B 9.26B 3.61B 47.02B 3.67B 3.59B 156B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-23 | ₹4,866.80 | -0.28% | 568 |
| 26-08-21 | ₹4,880.50 | -2.29% | 9,740 |
| 26-08-20 | ₹4,994.90 | -0.36% | 6,219 |
| 26-08-19 | ₹5,013.00 | +0.76% | 88,307 |
| 26-08-18 | ₹4,975.00 | +1.63% | 14,690 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TORNTPHARM Stock
Select your edition
All financial news and data tailored to specific country editions
